Alerts

Stryker is conducting a Critical Product Correction of Pad-Paks used with the HeartSine samaritan Public Access Defibrillator (PAD), with an expiry date range between 17 April 2025 to 01 August 2029.

Stryker is conducting an urgent recall of certain lots of the HeartSine Samaritan Public Access Defibrillator Pak (PAD-PAK). Stryker is now attempting to reach the small percentage of customers affected.

Stryker is conducting an Urgent Recall of certain serial numbers of the HeartSine Defibrillators.

Stryker is conducting an urgent product correction of certain lots of the HeartSine Defibrillator. Stryker is now attempting to reach the small percentage of customers affected.

Owners and people responsible for HeartSine PAD 300/PAD 300P public access defibrillators are advised that Aero Healthcare, in consultation with the TGA, undertook a recall for product correction of some of these devices in November 2012 to correct certain battery and software problems that may affect the ability of the device to work in the event it is needed.

Pharmacists can substitute whichever brand and strength of nicorandil is available during the shortage.

We are advising that there are supply issues with Physeptone (methadone) tablets due to quality control problems.

Recall - potential risk of harm for children who access the button battery

We have made a Serious Scarcity Substitution Instrument (SSSI) that starts on 22 December 2025 and ends on 28 April 2026. The SSSI allows a pharmacist to dispense an equivalent quantity of clonidine 100 mcg tablets, if appropriate, without a new prescription

Pharmacists can substitute 10 mg simvastatin tablets during the shortage of the 5 mg tablets.

Recall - potential risk of harm for children who access the button battery

Clinical guidance for prescribers during the shortages is available.

Pharmacists can dispense 200 mg tablets during the shortage.

Find out about a software problem with the SmartDrive MX2+ App, for the PushTracker E2 and E3 wearable watches, causing safety issues for operating manual wheelchairs.

Update in relation to the safety and efficacy of low-dose codeine containing products

Insulet is advising they have received complaints of Omnipod DASH PDM/controller battery depletion as a result of the 3G network deactivation in the region.

The TGA has undertaken a safety review of andrographis - a herbal ingredient used in some complementary medicines.

The TGA has published the safety review of low does cannabidiol

We are advising that some polio vaccines produced between 1957 and 1963 were contaminated with SV40, a simian virus.

Medtronic Australasia is informing customers about the serious risk of valve infolding for EvolutePRO+ 34mm Transcatheter Aortic Valve (TAV), item code - EVPROPLUS-34US.

Hazard alert - firmware update to improve battery performance and cybersecurity

We have been notified of spontaneous disintegration of zirconia femoral head prostheses in some batches manufactured by Saint Gobain Céramiques Avancées Desmarquest.